SauveBio
Private Company
Funding information not available
Overview
SauveBio is a privately held, US-based contract research organization (CRO) providing specialized flow cytometry and fluorescence-activated cell sorting (FACS) services to the biotechnology and pharmaceutical sectors. The company leverages cutting-edge instrumentation, including the BD FACSymphony S6, and PhD-level scientific expertise to offer services ranging from strategic project support to full execution and analysis. Through strategic partnerships with companies like Biomere and Splice Histology, SauveBio is expanding its service portfolio to offer more integrated preclinical data packages, positioning itself as a critical partner in early-stage drug development and validation.
Technology Platform
Advanced flow cytometry and fluorescence-activated cell sorting (FACS) services utilizing instruments like the BD FACSymphony S6 and Invitrogen Attune NxT. Specializes in high-parameter immunophenotyping, single-nuclei RNA-seq support, Fluorescence Activated Mitochondria Sorting (FAMS), exosome characterization, and receptor occupancy studies.
Opportunities
Risk Factors
Competitive Landscape
Competes against large, full-service CROs (e.g., LabCorp, Charles River), other niche flow cytometry service providers, and academic core facilities. Differentiation is based on deep technical expertise, high-touch service, specialized applications like FAMS, and integrated offerings through partnerships.